503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-3.18%
Revenue decline while CRWD shows 16.83% growth. Joel Greenblatt would examine competitive position erosion.
-8.09%
Cost reduction while CRWD shows 13.12% growth. Joel Greenblatt would examine competitive advantage.
-0.77%
Gross profit decline while CRWD shows 18.23% growth. Joel Greenblatt would examine competitive position.
2.49%
Margin expansion exceeding 1.5x CRWD's 1.20%. David Dodd would verify competitive advantages.
6.23%
R&D growth less than half of CRWD's 13.98%. David Dodd would verify if efficiency advantage is sustainable.
16.51%
G&A growth above 1.5x CRWD's 10.32%. Michael Burry would check for operational inefficiency.
2.73%
Marketing expense growth less than half of CRWD's 11.01%. David Dodd would verify if efficiency advantage is sustainable.
-91.43%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
5.72%
Operating expenses growth less than half of CRWD's 11.76%. David Dodd would verify sustainability.
-2.07%
Total costs reduction while CRWD shows 12.08% growth. Joel Greenblatt would examine advantage.
10.86%
Similar interest expense growth to CRWD's 10.92%. Walter Schloss would investigate norms.
6.34%
D&A growth 50-75% of CRWD's 10.04%. Bruce Berkowitz would examine asset strategy.
-3.26%
EBITDA decline while CRWD shows 32.06% growth. Joel Greenblatt would examine position.
-0.42%
EBITDA margin decline while CRWD shows 41.85% growth. Joel Greenblatt would examine position.
-4.74%
Operating income decline while CRWD shows 19.45% growth. Joel Greenblatt would examine position.
-1.61%
Operating margin decline while CRWD shows 31.05% growth. Joel Greenblatt would examine position.
-57.27%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-6.00%
Pre-tax income decline while CRWD shows 18.19% growth. Joel Greenblatt would examine position.
-2.92%
Pre-tax margin decline while CRWD shows 29.97% growth. Joel Greenblatt would examine position.
-38.10%
Tax expense reduction while CRWD shows 2.27% growth. Joel Greenblatt would examine advantage.
-0.04%
Net income decline while CRWD shows 17.89% growth. Joel Greenblatt would examine position.
3.24%
Net margin growth below 50% of CRWD's 29.71%. Michael Burry would check for structural issues.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.21%
Share count reduction while CRWD shows 1.25% change. Joel Greenblatt would examine strategy.
-0.25%
Diluted share reduction while CRWD shows 1.25% change. Joel Greenblatt would examine strategy.